Ibanez, BorjaBundgaard, Henning2025-12-172025-12-172025-09-02Eur Heart J. 2025 Sep 2;46(33):3244-3246.https://hdl.handle.net/20.500.12105/27076REACT is funded by the Novo Nordisk Foundation and counts with the collaboration of companies providing in-kind contribution (Philips Healthcare, Zeiss, Bank of Santander). Other companies will be incorporated into the initiative through an in-kind contribution scheme. AI developments are funded through competitive grants from the Spanish Ministry of Digital Transformation and Public Function (NEXTGENERATION EU ‘AI-POCVUS-REACT’ and ‘ENPESA’). The initiative is designed, directed, and managed solely by the research team. Researchers have no conflicts of interest to declare related to the initiative.engVoRhttp://creativecommons.org/licenses/by-nc-nd/4.0/Attribution-NonCommercial-NoDerivatives 4.0 International40746204EUROPEAN HEART JOURNALopen access